The U.S. chiropractic market size was valued at USD 12.26 billion in 2017. It is projected to expand at a CAGR of 4.32% over the forecast period. The market growth largely depends on the treatment adoption from the patients who prefer non-invasive treatment of chronic pains. Increasing prescription pain drug abuse and awareness about this treatment are among the key factors responsible for global market growth.
Growing acceptance of chiropractic therapy is also attributed to the cost-saving advantages associated with visit to a chiropractor. Chiropractic treatment involves the application of traditional methods of massage and detection methods to diagnose and cure the pain.
Although, FDA does not approve most of the techniques in chiropractic treatment; it is the most-preferred method as it is affordable than prescription medicine and does not involve any harmful or dependence inducing drug substances. However, efforts undertaken by the FDA to produce and provide clinical support for chiropractic treatment would help improve the market expansion. Most of the patients taking up chiropractic treatment opt for long-time treatment and consult a chiropractor for chronic pains.
Recent times have seen a surge in the number of clinics, spas, rehab centers that are supported by well-established firms and smaller individual set ups as well. The market is currently expanding at a significant pace in U.S. supported by government regulations and specific set of rules to bring an order and safe use of the treatment method. However, lack of approved scientific evidence can hinder the market growth.
There a number of chiropractic studios and clinics in the country including solo and group entities at multiple locations in the form of franchises and chain clinics. For instance, as per the American Chiropractic Association, it is estimated that by 2020, there would be ~80,000 chiropractors in the country with an addition of over ~2500 new practitioners each year graduating from colleges.
This is seemingly direct result of a rise in the number of patients’ visits to chiropractors due to long-term, enhanced outcomes. Chiropractors treat an approximate 35 million patients each year in U.S., which has contributed to making the U.S. chiropractic industry a significant one and this is likely to boost the market growth.
In 2017, 95% of the past-year chiropractic users cited this therapy as an effective mode of treatment. Furthermore, 97% of the users have reported to visit chiropractors if they have back/neck pain. Chiropractic services are available in the country in federal health delivery systems that cover the U.S. Departments of Veterans Affairs & Defense, Federal Workers’ Compensation, Medicaid, all state workers compensation programs, and Federal Employees Health Benefits Program.
States across the country are looking for an alternative pain treatment to address the growing issues of opioid addiction crisis. This, in turn, has created lucrative growth opportunities for chiropractic service providers. Health agencies and organizations are witnessing decrease in the prescription rate for opioids. This is primarily due to increased adoption of alternative pain treatments including chiropractic therapies. A substantial number of health organizations have fomented doctors to reduce the opioid prescriptions as nearly 34,500 people died from opioid overdoses.
As chiropractic care significantly addresses age-related problems, such as balance problems and falls, demand for this treatment is expected to grow in near future. Lower back pain and related symptoms, including decreased mobility, slow reaction time, and lower extremity weakness, are some of the contributing factors that cause balance and fall problems in older age. Chiropractic services help restore joint mobility improving balance problems. As per some research activities, significant reduction in pain was observed for patients who underwent chiropractic care for the treatment of back and balance issues.
Some of the active institutes that offer chiropractic services in U.S. market are Magen David Community Center, Inc.; The Joint Corp.; Lbi Starbucks DC 3; Allied Health of Wisconsin, S.C., P.C.; Sherman College of Straight Chiropractic, Inc.; Chiropractic Strategies Group, Inc.; Chiro One Wellness Centers, LLC; Landmark Healthcare Services, Inc.; Parsons Gregory V Advanced Chiropractic Clinic; Silverman Chiropractic Center, DC PCA; Emergency Chiropractic PC; and Multi-Specialty Healthcare Group, LLC.
Factors, such as increased awareness and various government initiatives like the FDA aiming to obtain clinical data to support this therapy, are likely to boost the market growth in the forecast period.
Attribute |
Details |
Base year for estimation |
2017 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Market representation |
Revenue in USD billion and CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the U.S. chiropractic market report on the basis of location and entity type:
Location Outlook (Revenue, USD Billion, 2014 - 2025)
West
Urban
Suburban
Rural
South
Urban
Suburban
Rural
Midwest
Urban
Suburban
Rural
East
Urban
Suburban
Rural
Entity Type Outlook (Revenue, USD Billion, 2014 - 2025)
Solo Clinic
Clinic
Wellness Centre
Medical Spa
Rehab Centre
Franchise
Group
Clinic
Wellness Centre
Rehab Centre
Franchise
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.